Prof Miles Prince states, “This compelling outcome fuels my enthusiasm to advance into a Phase 2 study. I am hopeful that expanding this research will provide a beacon of hope for patients facing limited treatment options and poor anticipated outcomes.”
That doesn't need my commentary!!! Well done PTX.
